대한의생명과학회지 (Biomedical Science Letters)

  • 제29권4호
  • /
  • Pages.355-362
  • /
  • 2023
  • /
  • 1738-3226(pISSN)
  • /
  • 2288-7415(eISSN)
대한의생명과학회 (The Korean Society for Biomedical Laboratory Sciences)
권호 표지
DOI QR코드

DOI QR Code

Longitudinal Relationships between Cigarette Smoking and Increases Risk for Incident Metabolic Syndrome: 16-year Follow-up of the Korean Genome and Epidemiology Study (KOGES)

  • Sang Shin Pyo (Department of Biomedical Laboratory Science, Jungwon University)
  • 투고 : 2023.11.26
  • 심사 : 2023.12.05
  • 발행 : 2023.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

This study aimed to determine whether smoking affects the metabolic syndrome and its components through long-term follow-up. Of the 10,030 cohort subjects in the community-based Korean Genome and Epidemiology Study (KoGES) from 2001 to 2018, 2,848 people with metabolic syndrome and 4,854 people with insufficient data for analysis were excluded for this study. The study population comprised 2,328 individuals (1,123 men, 1,205 women) who were eligible for inclusion. The mean age of the participants was 49.2±7.5 years, and 21.9% were current smoker. In log rank test, current smoker had a significantly higher cumulative incidence of metabolic syndrome compared with non smoker (P<0.001). In the Cox proportional hazards model adjusted for key variables, metabolic syndrome (hazard ratio [HR] 1.57, P<0.001), high fasting glucose (HR 1.40, P<0.01), hypertriglyceridemia (HR 1.60, P<0.001), low HDL-cholesterol (HR, 1.30, P<0.01), and abdominal obesity (HR 1.32, P<0.01) in current smoker compared with non smoker were statistically significant, respectively, but not hypertension (HR 1.00, P>0.05). After adjustment for confounders, the time (P-time<0.001) and group (P-group<0.001) effects on metabolic syndrome score change were statistically significant. Furthermore, the interaction analysis of time and smoking group on the change in metabolic syndrome score was statistically significant (P-interaction<0.001). In long-term follow-up, smoking worsens metabolic syndrome.

키워드

참고문헌

  1. Balhara YP. Tobacco and metabolic syndrome. Indian J Endocrinol Metab. 2012. 16: 81-87. https://doi.org/10.4103/2230-8210.91197
  2. Bertoni N, de Almeida LM, Szklo M, Figueiredo VC, Szklo AS. Assessing the relationship between smoking and abdominal obesity in a national survey of adolescents in brazil. Prev Med. 2018. 111: 1-5. https://doi.org/10.1016/j.ypmed.2018.02.017
  3. Cena H, Fonte ML, Turconi G. Relationship between smoking and metabolic syndrome. Nutr Rev. 2011. 69: 745-753. https://doi.org/10.1111/j.1753-4887.2011.00446.x
  4. Choi HI, Lee SJ, Kang JG, et al. Association of environmental tobacco smoke exposure with metabolic syndrome: A longitudinal cohort study of 71,055 never smokers. Nutr Metab Cardiovasc Dis. 2022. 32: 2534-2543. https://doi.org/10.1016/j.numecd.2022.07.009
  5. Edwards TC, Guest B, Garner A, et al. The metabolic equivalent of task score: A useful metric for comparing high-functioning hip arthroplasty patients. Bone Joint Res. 2022. 11: 317-326. https://doi.org/10.1302/2046-3758.115.BJR-2021-0445.R1
  6. GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: A systematic analysis from the global burden of disease study 2019. Lancet. 2021. 397: 2337-2360. https://doi.org/10.1016/S0140-6736(21)01169-7
  7. Gowing LR, Ali RL, Allsop S, et al. Global statistics on addictive behaviours: 2014 status report. Addiction. 2015. 110: 904-919. https://doi.org/10.1111/add.12899
  8. Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009. 2: 231-237. https://doi.org/10.1242/dmm.001180
  9. Kim BY, Kang SM, Kang JH, et al. 2020 korean society for the study of obesity guidelines for the management of obesity in korea. J Obes Metab Syndr. 2021. 30: 81-92. https://doi.org/10.7570/jomes21022
  10. Kim JH, Shim KW, Yoon YS, et al. Cigarette smoking increases abdominal and visceral obesity but not overall fatness: An observational study. PLoS ONE. 2012. 7.
  11. Kim Y, Han B-G, Group tK. Cohort profile: The korean genome and epidemiology study (koges) consortium. Int J Epidemiol. 2016. 46: e20-e20. https://doi.org/10.1093/ije/dyv316
  12. Leone A. Smoking and hypertension: Independent or additive effects to determining vascular damage? Curr Vasc Pharmacol. 2011. 9: 585-593. https://doi.org/10.2174/157016111796642706
  13. Li G, Wang H, Wang K, et al. The association between smoking and blood pressure in men: A cross-sectional study. BMC Public Health. 2017. 17: 797.
  14. Li Y, Hecht SS. Carcinogenic components of tobacco and tobacco smoke: A 2022 update. Food Chem Toxicol. 2022. 165: 113179.
  15. Lycett D, Munafo M, Johnstone E, Murphy M, Aveyard P. Associations between weight change over 8 years and baseline body mass index in a cohort of continuing and quitting smokers. Addiction. 2011. 106: 188-196. https://doi.org/10.1111/j.1360-0443.2010.03136.x
  16. Oberg M, Jaakkola MS, Woodward A, Peruga A, Pruss-Ustun A. Worldwide burden of disease from exposure to second-hand smoke: A retrospective analysis of data from 192 countries. Lancet. 2011. 377: 139-146. https://doi.org/10.1016/S0140-6736(10)61388-8
  17. Oncken CA, White WB, Cooney JL, et al. Impact of smoking cessation on ambulatory blood pressure and heart rate in postmenopausal women. Am J Hypertens. 2001. 14: 942-949. https://doi.org/10.1016/S0895-7061(01)02147-1
  18. Papathanasiou G, Zerva E, Zacharis I, et al. Association of high blood pressure with body mass index, smoking and physical activity in healthy young adults. Open Cardiovasc Med J. 2015. 9: 5-17. https://doi.org/10.2174/1874192401509010005
  19. Recio-Rodriguez JI, Gomez-Marcos MA, Patino-Alonso MC, et al. Abdominal obesity vs general obesity for identifying arterial stiffness, subclinical atherosclerosis and wave reflection in healthy, diabetics and hypertensive. BMC Cardiovasc Disord. 2012. 12: 3.
  20. Rezaei S, Akbari Sari A, Arab M, Majdzadeh R, Mohammad Poorasl A. Economic burden of smoking: A systematic review of direct and indirect costs. Med J Islam Repub Iran. 2016. 30: 397.
  21. Rigotti NA, Kruse GR, Livingstone-Banks J, Hartmann-Boyce J. Treatment of tobacco smoking: A review. JAMA. 2022. 327: 566-577. https://doi.org/10.1001/jama.2022.0395
  22. Rogers JM. Smoking and pregnancy: Epigenetics and developmental origins of the metabolic syndrome. Birth Defects Res. 2019. 111: 1259-1269. https://doi.org/10.1002/bdr2.1550
  23. Shin HS, Oh JE, Cho YJ. The association between smoking cessation period and metabolic syndrome in korean men. Asia Pac J Public Health. 2018. 30: 415-424. https://doi.org/10.1177/1010539518786517
  24. Sleight P. Smoking and hypertension. Clin Exp Hypertens. 1993. 15: 1181-1192. https://doi.org/10.3109/10641969309037104
  25. Takeuchi T, Nakao M, Nomura K, Yano E. Association of metabolic syndrome with smoking and alcohol intake in japanese men. Nicotine Tob Res. 2009. 11: 1093-1098. https://doi.org/10.1093/ntr/ntp106
  26. Walicka M, Russo C, Baxter M, et al. Impact of stopping smoking on metabolic parameters in diabetes mellitus: A scoping review. World J Diabetes. 2022. 13: 422-433. https://doi.org/10.4239/wjd.v13.i6.422
  27. Ward MM, Swan GE, Jack LM, Javitz HS, Hodgkin JE. Ambulatory monitoring of heart rate and blood pressure during the first week after smoking cessation. Am J Hypertens. 1995. 8: 630-634. https://doi.org/10.1016/0895-7061(95)00042-N
  28. West R. Tobacco smoking: Health impact, prevalence, correlates and interventions. Psychol Health. 2017. 32: 1018-1036. https://doi.org/10.1080/08870446.2017.1325890
  29. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: A systematic review and meta-analysis. JAMA. 2007. 298: 2654-2664. https://doi.org/10.1001/jama.298.22.2654